Smith, Moore & Co. Merck & Co., Inc. Transaction History

Smith, Moore & Co.

$1.03 Billion
Q3 2024

A detailed history of Smith, Moore & Co. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Smith, Moore & Co. holds 22,137 shares of MRK stock, worth $2.12 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

22,137

Previous 21,141 4.71%

Holding current value

$2.12 Million

Previous $2.62 Million 3.97%

% of portfolio

0.24%

Previous 0.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $110,705 - $128,454	996 Added 4.71%	22,137 $2.51 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $171,958 - $184,681	1,389 Added 7.03%	21,141 $2.62 Million
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $16,646 - $19,396	-147 Reduced 0.74%	19,752 $2.61 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $10,919 - $11,883	-109 Reduced 0.54%	19,899 $2.17 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $18,222 - $20,236	-177 Reduced 0.88%	20,008 $2.06 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $94,925 - $103,464	874 Added 4.53%	20,185 $2.33 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $81,425 - $90,854	-791 Reduced 3.93%	19,311 $2.05 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $63,743 - $81,728	729 Added 3.76%	20,102 $2.23 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $3,719 - $4,178	-44 Reduced 0.23%	19,373 $1.67 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $215,237 - $243,981	2,578 Added 15.31%	19,417 $1.77 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $39,033 - $43,754	531 Added 3.26%	16,839 $1.38 Million
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $72,858 - $91,264	1,008 Added 6.59%	16,308 $1.25 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $81,715 - $89,866	1,140 Added 8.05%	15,300 $1.15 Million
Q2 2021 Aug 10, 2021	BUY	$70.31 - $77.77 $108,839 - $120,387	1,548 Added 12.27%	14,160 $1.1 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $195,837 - $230,676	2,844 Added 29.12%	12,612 $972,000
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $245,596 - $272,562	-3,422 Reduced 25.94%	9,768 $799,000
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $126,820 - $143,752	1,733 Added 15.13%	13,190 $1.09 Million
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $10,422 - $11,859	-148 Reduced 1.28%	11,457 $886,000
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $251,539 - $348,645	3,970 Added 52.0%	11,605 $893,000
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $202,561 - $228,566	-2,611 Reduced 25.48%	7,635 $694,000
Q3 2019 Nov 07, 2019	SELL	$76.08 - $82.93 $6,238 - $6,800	-82 Reduced 0.79%	10,246 $862,000
Q2 2019 Aug 15, 2019	BUY	$69.84 - $81.59 $1,257 - $1,468	18 Added 0.17%	10,328 $866,000
Q1 2019 May 07, 2019	BUY	$69.58 - $79.36 $23,309 - $26,585	335 Added 3.36%	10,310 $857,000
Q4 2018 Feb 15, 2019	SELL	$65.24 - $75.71 $11,808 - $13,703	-181 Reduced 1.78%	9,975 $762,000
Q3 2018 Nov 15, 2018	BUY	$57.69 - $67.84 $2,076 - $2,442	36 Added 0.36%	10,156 $721,000
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $40,664 - $47,776	800 Added 8.58%	10,120 $614,000
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $12,689 - $14,748	249 Added 2.75%	9,320 $508,000
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $7,897 - $9,430	153 Added 1.72%	9,071 $510,000
Q3 2017 Nov 02, 2017	BUY	$58.67 - $63.13 $523,219 - $562,993	8,918	8,918 $571,000

Others Institutions Holding MRK

# of Institutions

3,815

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $242B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.

Account